In Silico Screening and Testing of FDA-Approved Small Molecules to Block SARS-CoV-2 Entry to the Host Cell by Inhibiting Spike Protein Cleavage
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14061129
Abstract: The COVID-19 pandemic began in 2019, but it is still active. The development of an effective vaccine reduced the number of deaths; however, a treatment is still needed. Here, we aimed to inhibit viral entry… read more here.
Keywords: protein; host cell; protein cleavage; entry host ... See more keywords